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1. Introduction 
Post-heparin plasma (PHP) from human subjects 
has been.shown to contain three distinct triacylglycerol 
lipases [ 1 ] . One of these is the protamine insensitive 
triacylglycerol lipase [2-41 and the other two are 
the protamine sensitive lipoprotein lipases (LPLs). 
The two LPLs are distinguishable on the basis of 
activation by C-I and C-II polypeptides of ApoC [ 1 ] . 
The C-I activated LPL, LPL,, was found to be 
absent in the PHP of subjects with Type I hyperlipo- 
proteinemia and was diminished to less than 40% in 
subjects with Type V hyperlipoproteinemia [5]. On 
the other hand, PHP from patients with Type III 
hyperlipoproteinemia was found to be deficient in 
concentration and enzyme activity of LPL,_l, while 
no abnormality of LPk_I was observed [5]. In these 
same studies it was found that the hydrolysis of CM-TG 
of chyle was only 10% of control values when CM 
were incubated with LPLs from PHP of Type I. 
Since Type I subjects have elevated CM but not VLDL, 
and Type III subjects have elevated LDLl and VLDL 
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but not CM, these results suggested that two LPLs may 
have different specificities for TG carried in CM and 
VLDL. The purpose of this study was to investigate 
the hydrolysis of TG from plasma CM, VLDL and 
LDL, by highly purified LPk_l isolated from PHP of 
normolipidemic subjects. 
2. Materials and methods 
2.1. Collection of post-heparin plasma 
Normolipidemic healthy volunteers of either sex 
(18-27 years) served as donors of PHP. After an 
overnight fast (14 h) 100 units/kg body wt (maximal 
dose was 10 000 units) heparin sodium (Upjohn Co., 
Kalamazoo, MI.) was administered intravenously and 
the blood drawn 30 min later into chilled plastic bags 
containing 50 ml of 4% sodium citrate. Plasma was 
separated by centrifugation at 4500 rev/min for 10 
min at 4°C and stored at -15°C until further use. 
2.2. Isolation and purification of LPLC_l 
The LPLs were isolated from three units (1320 ml) 
of PHP by a procedure utilizing enzyme-substrate 
complex formation followed by calcium phosphate 
gel chromatography [5]. The separation of LPLc_I 
from LPk_II was carried out by gel filtration in 
Sephadex G-l 00 as previously described [ 1,5]. 
2.3. Isolation of lipoprotein substrates 
CM were obtained from the plasma of normolipid- 
emit healthy donors 4 h after the ingestion of a 
fatty meal comprising 1300 cal(9OOcal from fat). 
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Three types of fatty meals were used: dairy cream, 
Lipomul@ (primarily corn oil, Upjohn Co., Kalamazoo 
MI.) or safflower oil containing malt. Preservative, 
solution containing 5% EDTA, 5% thimerosal, 5% 
sodium azide and 0.1 M DFP was added to the 
plasmapheresis bag (l/100 of plasma volume). 
Polyallomer tubes containing 30 ml plasma were 
layered with 5 ml 0.85% NaCl solution containing 
0.05% EDTA. CM were isolated by ultracentrifugation 
in a swinging bucket rotor SW 27 at 20 000 rev/mm at 
4°C for 30 min. CM floating to the top were collected 
and washed 5 times by recentrifugation after layering 
5,10,10,25 and 25 ml 0.85% NaCl + 0.05% EDTA 
solution on top of 30,25,25,10 and 10 ml CM, 
respectively. 
Outdated plasma (less than a month old) from 
non-fasted donors obtained from the blood bank was 
the source of VLDL and LDL, Normolipidemic 
plasma (serum TG < 170 mg/dl, TC < 260 mg/dl), 
and plasma from subjects who had normal TC but 
elevated TG (180-405 mg/dl of serum) were pooled 
separately. VLDL and LDLr were isolated either by 
ultracentrifugation according to the procedures 
described previously [6] or by phosphotungstate 
precipitation [7]. Both VLDL and LDL, were 
recentrifuged until free of albumin as tested by 
double diffusion with antibodies to albumin. 
Lipoproteins were then dialyzed against several 
changes of 0.15 M NaCl containing 0.05% EDTA, 
pH 7.0, prior to chemical analysis. DFP and NaN, 
were added back to the lipoproteins to be used as 
substrate to 1 mM and 0.05% respectively for preserva- 
tion. 
2.4. Protein and lipid analyses 
A modified version of the Lowry method [8] as 
described by Gustafson et al. [9] was used to 
determine the protein content of lipoproteins. A 
micro adaptation of the Lowry method [8] was used 
to determine the protein content of enzyme. TG were 
determined by the Autoanalyzer [lo] . The esteritied 
and unesteritied cholesterol and phospholipids were 
determined according to methods described previously 
161. 
2.5. Polyacrylamide-gel elec trophoresis 
The enzyme preparations and lipoprotein fractions 
were analyzed by electrophoresis in 7% polyacrylamide 
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gel containing 8 M urea in basic [l I] and acidic [12] 
buffers and the polypeptide bands were identified as 
described previously [5,13,14]. 
2.6. Immunochemical method 
The immunochemical properties of lipoprotein 
fractions were studied by double diffusion with 
monospecific antibodies to all known apolipoproteins 
and their polypeptides as described previously [ 131. 
2.7. Assays of lipolytic activity 
Lipolytic activity of enzyme preparations was 
measured with [ 14C] triolein emulsified in Triton 
X-l 00 as described previously [ 1 ] . Incubations were 
carried out at 37°C for 30 min or 1 h. Fatty acids 
(FA) were extracted by the method of Schotz et al. 
[ 151, and the radioactivity counted by Packard 
Liquid Scintillation Spectrometer. 
2.8. Hydrolyses of physiological substrates with 
purified LPL,, 
The physiological substrates were assayed in the 
following mixture (per ml): 3 mg of TG from CM, 
VLDL or LDL, , 120 mg of defatted human albumin 
(Sigma Chemicals, St. Louis, MO.) and 25 pmoles of 
(NH4), S04, pH 8.5. Lipoproteins in 0.15 M NaCl 
solution containing all preservative agents except 
thimerosal were concentrated to 1 O-l 5 mg TG/ml 
prior to use. Either 0.2 ml of PHP or purified LPk_l 
at a concentration of 2-3 pg per ml of assay mixture, 
unless otherwise stated, was added and the mixture 
was incubated at 37°C. The extraction of FFA from 
two 0.5 ml aliquots at specified time intervals and 
titration has been previously described [ 161 . 
3. Results and discussion 
3.1. Characterization of substrates 
3.1 .l. Characterization of protein moieties of lipo- 
protein substrates 
The immunochemical and electrophoretic studies 
demonstrated the presence of ApoB, C-I, C-II, C-III 
and ApoE in VLDL and LDLi . ApoD was found only 
in VLDL and LDL, isolated from plasma of hyperglycer 
idemic subjects. CM from subjects consuming any of 
the three different types of fat meals contained all of 
these peptides. Immunodiffusion pattern showed that 
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in CM, ApoC was in association with ApoD and ApoE 
but not with ApoB. A-I, A-II and albumin were 
frequently found in CM preparations, but they were 
not in association with either ApoB or ApoC: ApoD: 
ApoE complex, After six recentrifugations, two CM 
preparations were found to be free of immunochemi- 
tally detectable albumin, A-I and A-II. These studies 
indicated that albumin is not an integral component 
of CM. They also cast serious doubt as to the question 
whether A-I and A-II polypeptides are the intrinsic 
protein components of these lipoprotein particles 
[171* 
3.1.2. Chemical composition of lipoprotein substrates 
The percent chemical compositions of CM, VLDL 
and LDL, are shown in table 1. No significant difference 
was observed in the lipid composition of CM produced 
by different fat meals, although the FA composition 
of TG was distinct for each type of fatty meal. The 
CM-TG were rich in C16, C,,, and C,a_, FA for 
subjects taking dairy cream, I_ipomul@ and safflower 
oil, respectively. The most striking difference between 
the three density fractions was in the TG/CE ratio, 
i.e., TG/CE ratio decreases with increasing density 
of lipoproteins. There was no difference between VLDL 
isolated from normolipidemic and hypertriglyceridemic 
plasma. It is interesting to note that the chemical 
position of LDLr isolated from hypertriglyceridemic 
plasma. It is interesting to note that the chemical compo 
sition of LDL, isolated from hypertriglyceridemic 
normolipidemic plasma LDLr). 
3.2. Hydrolyses of TG in CM, VLDL and LDLl 
The results of assays with [r4C] triolein emulsion 
to which C-I and C-II were added as activators 
indicated that LPL eluted in the first fraction from 
Sephadex G-100 column was indeed C-I activated LPL 
(LPh_I in Table 2). The hydrolysis rates of CM, 
VLDL, LDLI and triolein emulsion with or without 
the addition of C-I or C-II by either LPLc_I or PHP are 
shown in Table 2. The data in this table indicate that : 
(1) the CM are the preferred physiologic substrates 
for LPk_I: (2) the CM-TG, rich in Cl6 and C1,I FA 
were far better substrates for LPL,, than those 
containing C,,, : (3) the hydrolytic rates for CM-TG 
rich in C16 and CI,, FA were 100 times greater than 
those for TG in VLDL and LDL, , and 10 times greater 
than those for artificial substrate, triolein and C-I; the 
hydrolytic rate for CM-TG rich in Cl,, FA was 4-6- 
fold higher than those for VLDL and LDL, , and was 
Table 1 
Percent chemical composition of chylomicrons, VLDL and LDLla 
Lipoprotein 
preparations 
Protein Phospholipids Cholesterol esters Free cholesterol Triacylglycerols Free fatty 
acids 
Chylomicrons N.I. 5.90 f 2.04 3.45 f 1.11 1.34 k 0.43 88.68 ? 3.34 0.31 + 0.31 
(n=5) 
VLDL 9.37 * 0.96 18.03 + 2.60 12.80 f 3.46 5.61 f 0.90 55.35 * 5.76 N.I. 
(n=7) 
(Normolipidemic) NJ. 19.61 * 2.83 13.92 + 3.76 6.10 + 0.98 60.21 * 6.27 0.15 f 0.65 
VLDL 9.23 f 1.59 18.29 f 3.10 10.58 + 1.15 4.83 f 1.52 57.07 % 3.62 N.I. 
(n=3) 
(High plasma TG) N.I. 20.03 * 3.39 11.58 f 1.26 5.29 * 1.66 62.49 r 3.96 0.61 
LDLl 17.97 * 3.91 24.24 i 1.23 22.71 f 5.01 5.76 f 1.77 29.49 ?r 3.97 N.I. 
(n=5) 
(Normolipidemic) N.I. 29.37 f 1.49 27.51 + 6.07 6.98 f 2.14 35.73 ? 4.81 0.41 f 0.23 
LDLl 12.78 + 0.29 21.08 f 1.07 32.73 + 2.46 7.35 k 2.36 26.11 + 6.21 N.I. 
(n=2) 
(High plasma TG) N.I. 24.02 f 1.21 37.29 f 2.80 8.37 i: 2.68 29.75 f 7.07 0.55 k 0.46 
a Mean f S.D.; n = number of experiments; N.I. = data not included in the calculation. 
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Table 2 
Hydrolyses of natural and artificial triacylglycerol substrates by LPLC_I and PHPa 
Experiments LPLC_I PHP 
Chylo- VLDL LDLl Triolein Triolein Triolein Chylo- VLDL LDLl Triolein 
microns + C-I + C-II microns 
lb 4.3 - - 18.8 
2b,c 52.70 0.30 0.50 2.57 - - 1.5 2.65 - 7.40 
(20.51) (0.11) (0.19) (1) 
___- 
3b,c,d 
(44;50) 
0 0 0.10 0.0 0.0 4.62 2.37 2.47 19.92 
(0) (0) (1) (0) (0) 
4e,f 50.15 0.54 0.28 2.60 0.08 0.05 6.8 - - 19.25 
(19.29) (0.21) (0.11) (1) (0.03) (0.02) 
5g,f 5.78 1.15 0.90 7.25 9.75 5.00 4.62 11.50 
(0.80) (0.16) (0.12) (1) c:p ,i;” 
aThe rates were expressed as pmoles FFA/ml enzyme or PHP (equivalent to 5 ml assay mixture) measured at 30 min. Numbers in 
parentheses were the relative rates. 
bChylomicrons isolated from donors who had taken dairy cream. 
‘VLDL and LDLI, isolated from normolipidimic donors. 
dThe LPL C-I enzyme concentration was approximately one-tenth the usual concentration. 
eChylomicrons isolated from donors who had taken LipomuI@. 
fVLDL and LDLl isolated from donors with elevated serum TG levels. 
gChyIomicrons isolated from donors who had taken safflower oil. 
Note: The PHP in each experiment was not necessarily the same parent PHP from which LPLC_I was isolated. However, the 
substrates in each experiment were identical for the comparison between LPLC_I and PHP. 
0.8 times that of artificial substrate with C-I: (4) there 
was no difference in the hydrolytic rates between 
VLDL and LDLI isolated either from normolipidemic 
or hypertriglyceridemic plasma: and (5) LPk_I hydro- 
lyzed CM-TG rich in Cl6 and Cra_, FA generally at a 
much higher rate than PHP, whereas the opposite was 
true for the CM-TG rich in C, 8_2. 
3.3. Kinetic studies on the hydrolysis of physiological 
substrates by LPLC_l 
The plots of log [S] vs time of incubation for 
Experiment 3 and 5 are shown in fig.1. Similar to the 
to the data shown in table 2, the hydrolyses of VLDL 
and LDL, were either zero or minimal. The hydrolyses 
of both CM preparations proceeded at a constant rate 
only during the initial 10 min. In some cases, the rate 
appeared to increase after 30 min. Sometimes the 
concentration of titratable FFA were higher than the 
expected FA content in TG after incubation for more 
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than 60 min. This phenomenon was particularly 
frequent with TG of CM rich in polyunsaturated FA 
and also when the LPk_r activity was relatively high. 
It was thought that lipid peroxidation may have occur- 
red during lengthy incubation (even in the presence of 
EDTA), and the oxidative products when extracted 
with Dole mixture, might behave like an acid. There- 
fore, antioxidant was added to these assay mixtures 
to prevent this phenomenon. Indeed, addition of 
0.02% glutathione to the incubation mixture prevented 
the occurrence of excessive titratable FFA (fig.1). 
3.4. Inhibition studies 
Protamine sulfate and 1 N NaCl are the inhibitors 
of LPLs and PHP [ 1 ,5] . In the present study DFP, 
NaN3, thimerosal, serum and d > 1.23 g/ml fraction 
of serum were also tested as potential inhibitors. 
NaNa (0.05%) increased PHP lipolytic activities 5%. 
This activating effect of NaNa was probably due to its 
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Fig.1. Kinetic behavior of LPL c-1 on lipoprotein substrates 
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chylomicrons, VLDL and LDLl. CM d.c., chylomicrons 
isolated from donors taking dairy cream; CM s.o., chylomicrons 
isolated from donors taking safflower oil; CM S.O. + Gluta., 
0.02% Glutathione was added to the incubation mixture 
containing CM S.O. Composition of the incubation mixture 
for these assays, method of extraction and measurement.of 
free fatty acids have been described under Materials and 
methods. 
stabilizing effect on the incubation mixture. At a 
concentration less than 0.5 mM DFP had no effect on 
PHP activities. Thimerosal was a potent inhibitor. 
Above 0.04%, it completely inhibited the PHP activi- 
ties. Addition of normal serum and d > 1.23 g/ml frac- 
tion of serum (in 0.85% NaCl + 0.05% EDTA) at 0.2 
ml/ml of assay mixture caused 22.6% and 88.8% 
inhibition of CM (polyunsaturated) hydrolysis by 
IJL, . 
At the present time we can only speculate about 
the reasons for the preferential hydrolysis of CM by 
LPLc_I. Among the possible explanations including a 
preferential size of lipoprotein particles, a preferred 
TG/CE ratio, a preferred PL/TG ratio, we favor the 
last one. Data in fig.2 shows that the optimal activator 
concentration of C-I is 5-60 pg/ 10 pmol of TG in a 
triolein emulsion or a C-I/TG weight ratio of 
0.6-0.68/100. Under identical conditions, 90 fig of 
C-I (corresponding to a l/ 100 ratio for C-I/TG) 
activated LPLc_l only 59% of the maximum obtained 
= LY 
OL I I 
0 10 30 60 90 
pg C-I/ml assay mixture 
Fig.2. Activation of LPL C-1 by C-l polypeptide. Assay 
mixture contained 10 pmol [“Cl triolein emulsified with 45 
pg Triton X-100, and other constituents as described 
previously [ 11. 
with 30 pg of C-I. Based on the assumption that C-I 
represents approximately 11% of CM protein [ 181, 
14% of VLDL and 11% of LDL, protein [19] and 
TG content of these lipoprotein classes (table l), it 
was calculated that the C-I/TG ratios for CM, VLDL 
and LDL, are 0.19/100,2.3/100 and 5-7/100, 
respectively. These calculations show that only CM 
have an optimal C-I/TG ratio. 
Conclusion 
This is the first report of the hydrolyses of physio- 
logic substrates by C-I activated LPL. Results show 
that CM are the preferred TG substrate. It is suggested 
that an optimal ratio of C-I/TG may be one of the 
factors for the substrate selectivity of LPk_1. CM 
derived from fat meals rich in Cl6 or C18_1, TG-fatty 
acids are better substrates than those derived from 
exogenous TG rich in Cl&z. A non-dialyzable serum 
factor present in d > 1.23 g/ml inhibits LP&-. 
The data presented in this paper lends further 
strength to the previous report [5] that in 
Type I hyperlipoproteinemic subjects, the accumulation 
of CM is due to the deficiency of LPk_*. The 
sequential release of LPk_1 and LPLc_1, in plasma 
after a fat meal [20] also suggests a significant 
physiologic role for LPk_1 in the hydrolysis of CM. 
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